Literature DB >> 2380989

Tamoxifen as a potential preventive agent in healthy postmenopausal women.

R L Prentice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2380989     DOI： 10.1093/jnci/82.16.1310

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

Review 1.  The menopause and hormone replacement therapy.

Authors:  K T Khaw
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

Review 2.  Gonadal hormone substitutes: effects on the cardiovascular system.

Authors:  T B Clarkson; J M Cline; J K Williams; M S Anthony
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen.

Authors:  J A Kalef-Ezra; N Pavlidis; G Klouvas; A Karantanas; I Hatzikonstantinou; D Glaros
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors:  P N Plowman
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

5.  The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977.

Authors:  K Mühlemann; L S Cook; N S Weiss
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.

Authors:  Y P Dragan; S Fahey; K Street; J Vaughan; V C Jordan; H C Pitot
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.